Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: Results from a randomized, placebo-controlled clinical trial.
CONCLUSIONS: Dupilumab improved QoLIAD scores in adults with AD and was significantly associated with improvements in study outcomes This article is protected by copyright. All rights reserved.
PMID: 28845523 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - Category: Dermatology Authors: Tsianakas A, Luger TA, Radin A Tags: Br J Dermatol Source Type: research
More News: Clinical Trials | Dermatitis | Dermatology | Eczema | Skin | Sleep Disorders | Sleep Medicine | Study | UK Health